Serotonergic modulation of 3,4-methylenedioxymethamphetamine (MDMA)-elicited reduction of response rate but not rewarding threshold in accumbal self-stimulation

被引:25
作者
Lin, HQ
Jackson, DM
Atrens, DM
Christie, MJ
McGregor, IS
机构
[1] UNIV SYDNEY, DEPT PSYCHOL, SYDNEY, NSW 2006, AUSTRALIA
[2] ASTRA RES CTR AB, CNS PRECLIN R & D, BEHAV PHARMACOL DEPT, S-15185 SODERTALJE, SWEDEN
基金
澳大利亚研究理事会;
关键词
3,4-methylenedioxymethamphetamine (MDMA); D-amphetamine; cocaine; methysergide; self-stimulation; performance; reinforcement; 5-HT;
D O I
10.1016/S0006-8993(96)01210-3
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
In a fixed interval 5-s rate-frequency function paradigm with rats, 3,4-methylenedioxymethamphetamine (MDMA; 0.5, 2 and 4 mg/kg) dose-dependently decreased response rate for nucleus accumbens self-stimulation while both D-amphetamine (0.3 and 1 mg/kg) and cocaine (5 and 15 mg/kg) increased response rates. The highest dose of MDMA caused a cessation of responding in many of the rats tested, but in those rats that continued to respond a significant reduction in frequency threshold for self-stimulation was seen. Cocaine and amphetamine dose-dependently reduced frequency threshold in all rats tested. The non-specific serotonin antagonist, methysergide (5 mg/kg), reversed the inhibitory effects of MDMA on response rates and caused all rats to respond following MDMA (4 mg/kg). Methysergide did not affect MDMA's threshold-lowering properties and when administered alone methysergide had no effect on self-stimulation. These results suggest serotonergic involvement in the performance but not reinforcement-modulating effect of MDMA in the self-stimulation paradigm.
引用
收藏
页码:351 / 357
页数:7
相关论文
共 38 条
[1]   MDL72222, A SEROTONIN 5-HT3 RECEPTOR ANTAGONIST, BLOCKS MDMAS ABILITY TO ESTABLISH A CONDITIONED PLACE PREFERENCE [J].
BILSKY, EJ ;
REID, LD .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1991, 39 (02) :509-512
[2]   MDMA PRODUCES A CONDITIONED PLACE PREFERENCE AND ELICITS EJACULATION IN MALE-RATS - A MODULATORY ROLE FOR THE ENDOGENOUS OPIOIDS [J].
BILSKY, EJ ;
HUBBELL, CL ;
DELCONTE, JD ;
REID, LD .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1991, 40 (02) :443-447
[3]  
BIRD M P, 1987, Society for Neuroscience Abstracts, V13, P1323
[4]  
BOSZORMENYI SH, 1987, RED P, V46, P545
[5]  
CALLAWAY CW, 1992, NEUROPSYCHOPHARMACOL, V7, P113
[6]  
CALLAWAY CW, 1990, J PHARMACOL EXP THER, V254, P456
[7]   THE ANTINOCICEPTIVE EFFECTS OF 3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA) IN THE RAT [J].
CRISP, T ;
STAFINSKY, JL ;
BOJA, JW ;
SCHECHTER, MD .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1989, 34 (03) :497-501
[8]   QUANTITATIVE-DETERMINATION OF THE EFFECTS OF CATECHOLAMINERGIC AGONISTS AND ANTAGONISTS ON THE REWARDING EFFICACY OF BRAIN-STIMULATION [J].
GALLISTEL, CR ;
FREYD, G .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1987, 26 (04) :731-741
[9]   FURTHER-STUDIES ON N-METHYL-1(3, 4-METHYLENEDIOXYPHENYL)-2-AMINOPROPANE AS A DISCRIMINATIVE STIMULUS - ANTAGONISM BY 5-HYDROXYTRYPTAMINE3 ANTAGONISTS [J].
GLENNON, RA ;
HIGGS, R ;
YOUNG, R ;
ISSA, H .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1992, 43 (04) :1099-1106
[10]   A ROLE FOR THE MESOLIMBIC DOPAMINE SYSTEM IN THE PSYCHOSTIMULANT ACTIONS OF MDMA [J].
GOLD, LH ;
HUBNER, CB ;
KOOB, GF .
PSYCHOPHARMACOLOGY, 1989, 99 (01) :40-47